The Droplette Micro-Infuser profoundly enhances drug delivery into the skin.
The Droplette Micro-Infuser was developed with patented technology, and the device profoundly enhances drug delivery into the skin. It uses advanced fluid physics to “inject ” clinical-strength formulations deep into the skin through a high-speed poweful, yet gentle, micro-mist.
Droplette’s microinfusion technology was initially developed to painlessly administer topical drugs for medical conditions such as Epidermolysis Bullosa, a debilitating skin disease.
The founders quickly realized the potential for the device in every realm of skincare.
Madhavi Gavini, CEO and co-founder of Droplette, says, “We are continuously striving to be at the forefront of technology and science. This award is further confirmation that Droplette is paving the way for the future of skincare and I am immensely proud that our hard work has received this prestigious recognition.”
In 2021 Droplette was awarded the Edison Award Gold Medal for Best New Product, and received an honorable mention for Fast Company’s 2021 World Changing Ideas Awards.
Droplette’s microinfusion technology was initially developed to painlessly administer topical drugs for medical conditions such as Epidermolysis Bullosa, a debilitating skin disease. The founders quickly realized the potential for the device in every realm of skincare. Gavini says Droplette can amplify everyday skincare routines with visible, clinically proven results.